FDAnews
www.fdanews.com/articles/198513-softwave-to-launch-study-of-wound-care-system-for-cellulite
SoftWave Tissue Regeneration Technologies logo

SoftWave to Launch Study of Wound Care System for Cellulite

August 13, 2020

SoftWave Tissue Regeneration Technologies said it plans to seek 510(k) clearance for its DermaGold 100 wound care system for the treatment of cellulite, supported by results from an upcoming study.

The 60-patient study will evaluate the device for the temporary improvement of cellulite appearance in women between the ages of 25 and 65 years.

The system is currently cleared by the FDA to use a combination of heat, electromagnetic acoustic and light to stimulate wound healing.

View today's stories